Meeder Asset Management Inc Regenxbio Inc. Transaction History

Meeder Asset Management Inc

$1.42 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $1,916 - $3,013	-86 Reduced 62.77%	51 $1,000
Q2 2022 Aug 08, 2022	BUY	$19.35 - $35.04 $561 - $1,016	29 Added 26.85%	137 $3,000
Q1 2022 May 10, 2022	BUY	$24.62 - $34.31 $2,658 - $3,705	108 New	108 $4,000
Q4 2021 Feb 11, 2022	SELL	$30.19 - $40.28 $43,564 - $58,124	-1,443 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$29.09 - $45.68 $39,446 - $61,942	1,356 Added 1558.62%	1,443 $60,000
Q2 2021 Aug 09, 2021	BUY	$32.46 - $40.48 $2,142 - $2,671	66 Added 314.29%	87 $3,000
Q4 2020 Feb 09, 2021	SELL	$26.52 - $49.35 $212 - $394	-8 Reduced 27.59%	21 $1,000
Q3 2020 Nov 02, 2020	SELL	$27.01 - $40.26 $1,728 - $2,576	-64 Reduced 68.82%	29 $1,000
Q2 2020 Aug 11, 2020	SELL	$27.75 - $43.44 $11,072 - $17,332	-399 Reduced 81.1%	93 $3,000
Q1 2020 May 15, 2020	BUY	$21.5 - $54.2 $2,945 - $7,425	137 Added 38.59%	492 $16,000
Q3 2019 Oct 17, 2019	BUY	$31.84 - $50.88 $8,342 - $13,330	262 Added 281.72%	355 $13,000
Q2 2019 Aug 05, 2019	SELL	$42.0 - $59.29 $89,418 - $126,228	-2,129 Reduced 95.81%	93 $5,000
Q1 2019 Apr 16, 2019	SELL	$40.82 - $62.45 $14,531 - $22,232	-356 Reduced 13.81%	2,222 $128,000
Q4 2018 Jan 17, 2019	BUY	$39.11 - $75.15 $24,287 - $46,668	621 Added 31.73%	2,578 $109,000
Q3 2018 Nov 02, 2018	SELL	$65.0 - $82.15 $14,365 - $18,155	-221 Reduced 10.15%	1,957 $0
Q2 2018 Jul 24, 2018	BUY	$27.2 - $74.35 $54,726 - $149,592	2,012 Added 1212.05%	2,178 $0
Q1 2018 May 03, 2018	SELL	$24.05 - $37.5 $4,569 - $7,125	-190 Reduced 53.37%	166 $5,000
Q4 2017 Feb 02, 2018	BUY	$26.0 - $34.6 $8,606 - $11,452	331 Added 1324.0%	356 $12,000
Q3 2017 Oct 20, 2017	BUY	$18.0 - $32.95 $450 - $823	25	25 $1,000

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $404M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account